82 related articles for article (PubMed ID: 29150923)
21. 8-Br-cGMP suppresses tumor progression through EGFR/PLC γ1 pathway in epithelial ovarian cancer.
Wu M; Mu C; Yang H; Wang Y; Ma P; Li S; Wang Z; Lan T
Mol Biol Rep; 2024 Jan; 51(1):140. PubMed ID: 38236447
[TBL] [Abstract][Full Text] [Related]
22. Type II cGMP-dependent protein kinase inhibits activation of key members of the RTK family in gastric cancer cells.
Jiang L; Chen Y; Sang J; Li Y; Lan T; Wang Y; Tao Y; Qian H
Biomed Rep; 2013 May; 1(3):399-404. PubMed ID: 24648957
[TBL] [Abstract][Full Text] [Related]
23. Type II cGMP-dependent protein kinase inhibits proliferation of the gastric cancer cell line BGC-823.
Chen YC; Ren F; Sang JR; Tao Y; Xu WR
Mol Med Rep; 2010; 3(2):361-6. PubMed ID: 21472248
[TBL] [Abstract][Full Text] [Related]
24. Protein Kinases Type II (PKG II) Combined with L-Arginine Significantly Ameliorated Xenograft Tumor Development: Is L-Arginine a Potential Alternative in PKG II Activation?
Wu Y; Liu Y; Cai Z; Qin H; Li H; Su W; Wang Y; Qian H; Jiang L; Wu M; Pang J; Chen Y
Med Sci Monit; 2018 Feb; 24():736-742. PubMed ID: 29401205
[TBL] [Abstract][Full Text] [Related]
25. Activation of the small GTPase Rac1 by cGMP-dependent protein kinase.
Hou Y; Ye RD; Browning DD
Cell Signal; 2004 Sep; 16(9):1061-9. PubMed ID: 15212766
[TBL] [Abstract][Full Text] [Related]
26. The constitutively active PKG II mutant effectively inhibits gastric cancer development
Wu Y; Yuan M; Su W; Zhu M; Yao X; Wang Y; Qian H; Jiang L; Tao Y; Wu M; Pang J; Chen Y
Ther Adv Med Oncol; 2018; 10():1758834017751635. PubMed ID: 29434677
[TBL] [Abstract][Full Text] [Related]
27. Increased endogenous PKG I activity attenuates EGF-induced proliferation and migration of epithelial ovarian cancer via the MAPK/ERK pathway.
Lan T; Li Y; Wang Y; Wang ZC; Mu CY; Tao AB; Gong JL; Zhou Y; Xu H; Li SB; Gu B; Ma P; Luo L
Cell Death Dis; 2023 Jan; 14(1):39. PubMed ID: 36653376
[TBL] [Abstract][Full Text] [Related]
28. Protein kinase G type Ialpha activity in human ovarian cancer cells significantly contributes to enhanced Src activation and DNA synthesis/cell proliferation.
Leung EL; Wong JC; Johlfs MG; Tsang BK; Fiscus RR
Mol Cancer Res; 2010 Apr; 8(4):578-91. PubMed ID: 20371672
[TBL] [Abstract][Full Text] [Related]
29. Structural Basis of Analog Specificity in PKG I and II.
Campbell JC; Henning P; Franz E; Sankaran B; Herberg FW; Kim C
ACS Chem Biol; 2017 Sep; 12(9):2388-2398. PubMed ID: 28793191
[TBL] [Abstract][Full Text] [Related]
30. CD24 associates with EGFR and supports EGF/EGFR signaling via RhoA in gastric cancer cells.
Deng W; Gu L; Li X; Zheng J; Zhang Y; Duan B; Cui J; Dong J; Du J
J Transl Med; 2016 Feb; 14():32. PubMed ID: 26830684
[TBL] [Abstract][Full Text] [Related]
31. Type II cyclic guanosine monophosphate-dependent protein kinase inhibits Rac1 activation in gastric cancer cells.
Wang Y; Chen Y; Wu M; Lan T; Wu Y; Li Y; Qian H
Oncol Lett; 2015 Jul; 10(1):502-508. PubMed ID: 26171059
[TBL] [Abstract][Full Text] [Related]
32. Time-dependent inhibitory effects of cGMP-analogues on thrombin-induced platelet-derived microparticles formation, platelet aggregation, and P-selectin expression.
Nygaard G; Herfindal L; Kopperud R; Aragay AM; Holmsen H; Døskeland SO; Kleppe R; Selheim F
Biochem Biophys Res Commun; 2014 Jul; 449(3):357-63. PubMed ID: 24845383
[TBL] [Abstract][Full Text] [Related]
33. Grape seed extract inhibits EGF-induced and constitutively active mitogenic signaling but activates JNK in human prostate carcinoma DU145 cells: possible role in antiproliferation and apoptosis.
Tyagi A; Agarwal R; Agarwal C
Oncogene; 2003 Mar; 22(9):1302-16. PubMed ID: 12618755
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of cGMP-dependent protein kinase by the cell-permeable peptide DT-2 reveals a novel mechanism of vasoregulation.
Taylor MS; Okwuchukwuasanya C; Nickl CK; Tegge W; Brayden JE; Dostmann WR
Mol Pharmacol; 2004 May; 65(5):1111-9. PubMed ID: 15102939
[TBL] [Abstract][Full Text] [Related]
35. Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells.
Gan Y; Shi C; Inge L; Hibner M; Balducci J; Huang Y
Oncogene; 2010 Sep; 29(35):4947-58. PubMed ID: 20562913
[TBL] [Abstract][Full Text] [Related]
36. Regulation of L-type Ca
Sandoval A; Duran P; Gandini MA; Andrade A; Almanza A; Kaja S; Felix R
Cell Calcium; 2017 Sep; 66():1-9. PubMed ID: 28807144
[TBL] [Abstract][Full Text] [Related]
37. Estrogen signaling via a linear pathway involving insulin-like growth factor I receptor, matrix metalloproteinases, and epidermal growth factor receptor to activate mitogen-activated protein kinase in MCF-7 breast cancer cells.
Song RX; Zhang Z; Chen Y; Bao Y; Santen RJ
Endocrinology; 2007 Aug; 148(8):4091-101. PubMed ID: 17525128
[TBL] [Abstract][Full Text] [Related]
38. Src promotes EGF-induced epithelial-to-mesenchymal transition and migration in gastric cancer cells by upregulating ZEB1 and ZEB2 through AKT.
Zhao L; Li X; Song N; Li A; Hou K; Qu X; Che X; Liu Y
Cell Biol Int; 2018 Mar; 42(3):294-302. PubMed ID: 29052277
[TBL] [Abstract][Full Text] [Related]
39. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.
Huang Y; Li X; Jiang J; Frank SJ
Oncogene; 2006 Dec; 25(58):7565-76. PubMed ID: 16785991
[TBL] [Abstract][Full Text] [Related]
40. Neutron Crystallography Detects Differences in Protein Dynamics: Structure of the PKG II Cyclic Nucleotide Binding Domain in Complex with an Activator.
Gerlits O; Campbell JC; Blakeley MP; Kim C; Kovalevsky A
Biochemistry; 2018 Mar; 57(12):1833-1837. PubMed ID: 29517905
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]